Literature DB >> 6249887

The immune response against the ASV-coded src-gene product in syngeneic mice.

A Huesgen, G Huesgen, J Stegmann, R Kurth.   

Abstract

The antigenicity of the avian sarcoma virus (ASV)-coded src-gene product pp60src, which is responsible for fibroblast transformation after ASV infection, has been investigated in STU mouse fibrosarcoma cell lines and the corresponding immune response in syngeneic mice has been determined. The development of effective anti-pp60src antibody titres depends on the mode and stie of injection of tumour cells and parallels tumour growth. It was found that mouse immunoglobulin heavy chains are unable to serve as substrate for the protein kinase activity of pp60src. Therefore, an indirect protein kinase absorption (PKA) test was initiated to demonstrate recognition of the protein kinase activity associated with the src-gene product. The availability of syngeneic mice and the corresponding ASV-transformed tumour cells should facilitate studies designed to elucidate the possible relationship between the cytoplasmic pp60src and ASV-induced tumour-specific surface antigens (TSSA), for example, by allowing the production of stable mouse hybridomas synthesizing antibodies specific for pp60src and TSSA.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6249887     DOI: 10.1099/0022-1317-48-2-401

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  3 in total

1.  Demonstration of avian sarcoma virus-coded pp60src in vivo and the anti-pp60src immune response in chickens.

Authors:  M Ellwart-Tschürtz; R Kurth
Journal:  J Virol       Date:  1981-09       Impact factor: 5.103

Review 2.  Oncogenes in retroviruses and cells.

Authors:  R Kurth
Journal:  Naturwissenschaften       Date:  1983-09

3.  Tankyrase inhibitor XAV-939 enhances osteoblastogenesis and mineralization of human skeletal (mesenchymal) stem cells.

Authors:  Nuha Almasoud; Nihal AlMuraikhi; Sarah Binhamdan; Ghaydaa Younis; Hanouf Alaskar; Amal Alotaibi; Muthurangan Manikandan; Musaad Alfayez; Moustapha Kassem
Journal:  Sci Rep       Date:  2020-10-07       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.